Johnson & Johnson
Soft chewable dosage form
Last updated:
Abstract:
The invention relates to a soft chewable dosage form comprising a first active pharmaceutical ingredient encapsulated in a lipid material that is embedded in the soft chewable dosage form and wherein the soft chewable dosage form comprises at least a second active pharmaceutical ingredient as well as a method of treating a subject suffering from a disease or disorder in the gastro intestinal tract using the soft chewable dosage form.
Status:
Grant
Type:
Utility
Filling date:
16 Oct 2019
Issue date:
12 Oct 2021